When businesses and consumers ramp up activities, UPS sees an uptick in package volumes, signaling economic growth and consumer confidence.
Conversely, a downturn in UPS’s business, such as a reduction in package volumes or revenue, can signal economic contraction or a looming recession. This sensitivity to the economic climate makes UPS’s operational metrics – from package volume to revenue trends – a barometer for assessing the overall health of the global economy.
When a company like this starts slashing jobs – 12,000 to be precise - it's an indicator. This is a staggering figure that’s more than just a number; it’s a harbinger of economic trends, both domestically and internationally. UPS’s decision is not an isolated event. The company’s package volume has slipped in the last quarter, a seemingly straightforward statement that carries significant weight. This decline is not just a corporate setback; it’s a reflection of broader economic softness, particularly in Europe.
The FDA has rejected its strongest safety warning for Covid mRNA vaccines despite acknowledging that children were killed by the products.
This news surfaced during a televised Bloomberg interview with FDA Commissioner Marty Makary, who said the agency has “no plans” to apply its strongest safety warning to Covid mRNA vaccines.
In that interview, Makary confirmed that the FDA’s own safety and epidemiology centre had formally recommended a boxed warning — a step reserved, under FDA rules, for drugs with “special problems, particularly ones that may lead to death or serious injury.”